Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
about
Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project).High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology StudyHIV Disclosure and Transmission Risks to Sex Partners Among HIV-Positive Men.A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.Influence of the First Consultation on Adherence to Antiretroviral Therapy for HIV-infected PatientsAdherence among rural HIV-infected patients in the deep south: a comparison between single-tablet and multi-tablet once-daily regimens.A framework for quantifying the influence of adherence and dose individualization.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.HIV-Related Stress and Life Chaos Mediate the Association Between Poverty and Medication Adherence Among People Living with HIV/AIDS.Opinion: the pharmacometrics of infectious disease.Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS.Adherence and virologic outcomes among treatment-naïve veteran patients with human immunodeficiency virus type 1 infection.
P2860
Q30827217-DE7E2207-15E0-43F8-BBE0-A037D8A92A66Q35808100-9F71C49C-963B-4EC1-8B77-8B174870CAA4Q36004031-2F421D52-7207-485F-9BBE-2E640823A241Q36910843-2E5685FA-6B6A-4BD9-B72E-D99B619E6D54Q37030734-9766EB1C-4096-44CB-B26E-DC150D6EFE18Q37286862-0D0F900C-778E-434C-B523-0FF4702814F3Q38261526-94528E83-90F6-4715-80DC-59D79DA408ABQ38882371-FB96E08E-CF5D-46E5-A673-3CFEB531BB78Q38954109-082B5ED7-A000-4180-A94A-70EF077B3DC8Q40441188-7B68FF27-6FF0-47F5-BD7E-776C21CAED95Q41850398-2F3690D2-9068-45ED-A20C-2AA28526355EQ45124259-B46F6F09-74A1-4A01-B9F9-3F99AF429E6DQ52685421-B14550F7-1B88-452B-8426-51F5F5F2E20E
P2860
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Adherence profiles and therape ...... n the ANRS 134-COPHAR 3 trial.
@en
type
label
Adherence profiles and therape ...... n the ANRS 134-COPHAR 3 trial.
@en
prefLabel
Adherence profiles and therape ...... n the ANRS 134-COPHAR 3 trial.
@en
P2093
P2860
P50
P356
P1476
Adherence profiles and therape ...... n the ANRS 134-COPHAR 3 trial.
@en
P2093
Anne-Marie Taburet
Aurélie Barrail-Tran
Cécile Goujard
France Mentré
Georges Nembot
Xavier Duval
Xavière Panhard
P2860
P304
P356
10.1128/AAC.02605-12
P407
P577
2013-03-04T00:00:00Z